Previous Close | 0.00 |
Open | 32.00 |
Bid | 27.04 x 36100 |
Ask | 28.00 x 41800 |
Day's Range | 32.00 - 32.00 |
52 Week Range | 18.72 - 46.05 |
Volume | |
Avg. Volume | 623 |
Market Cap | 2.209B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 13.86 |
EPS (TTM) | 2.03 |
Earnings Date | Nov 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Bavarian Nordic AS (BVNKF) reports robust travel health business growth and strategic advancements in vaccine launches amid logistical challenges.
Kennedy, a vaccine skeptic, has promised sweeping changes to food and drug regulation and government-funded scientific research.